SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Mechanism: cross-disease

mechanism 2,063 words KG: disease

Contents

cross-disease

⚙ Mechanism Info

Name	disease
Related Diseases	Cognitive Impairment, Bipolar, Pain
Linked Hypotheses	25 hypotheses

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 0.70 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Microbial Inflammasome Priming Prevention
Score: 0.58 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cryptic Exon Silencing Restoration
Score: 0.46

APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Cross-Seeding Prevention Strategy
Score: 0.45 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Circadian Clock-Autophagy Synchronization
Score: 0.55 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51 Early Proteasome Restoration Therapy
Score: 0.50 Transglutaminase-2 Cross-Linking Inhibition Strategy
Score: 0.49 Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49 Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.47 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 Complement C1q Subtype Switching
Score: 0.44 Low Complexity Domain Cross-Linking Inhibition
Score: 0.42 RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37 Synaptic Vesicle Tau Capture Inhibition
Score: 0.34 Quantum Coherence Disruption in Cellular Communication
Score: 0.34 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed

Related Experiments (30)

Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40

ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecu
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation in Huntington's Disease — Therapeut
validation · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Gap Junction Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40 Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40 Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40 Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in
clinical · proposed · Score: 0.40 Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism
clinical · proposed · Score: 0.40 Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.40

See Also (12)

ADRB2 Gene
gene · KG edge: associated_with ADRA2A Gene
gene · KG edge: associated_with ADORA2A Gene
gene · KG edge: interacts_with ADAM8 Gene
gene · KG edge: interacts_with ACTB Gene
gene · KG edge: activates

ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: regulates ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member
gene · KG edge: associated_with ABCD3 Gene
gene · KG edge: activates ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: associated_with ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: interacts_with A2M Gene
gene · KG edge: implicated_in ABCA7 (Redirect)
redirect · KG edge: activates

Knowledge Graph (12 edges)

disease activates PPAR-Γ

disease activates PEROXISOME

disease protects_against PPAR-Γ

disease protects_against NEURODEGENERATIVE DISEASE

disease associated_with ALZHEIMER'S

disease inhibits ALZHEIMER'S

disease interacts_with ALZHEIMER'S

disease protects_against ALZHEIMER'S

disease inhibits Cognitive Impairment

disease associated_with GENETIC MODIFIERS

SciDEX — scidex.ai — Dashboard | Atlas